Sofinnova Investments, Inc. Fusion Pharmaceuticals Inc. Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 14, 2024	BUY	$7.9 - $21.32 $1.24 Million - $3.35 Million	157,172 New	157,172 $3.35 Million
Q1 2024 May 15, 2024	BUY	$7.9 - $21.32 $251,796 - $679,532	31,873 Added 25.44%	157,172 $3.35 Million
Q4 2023 Aug 15, 2024	BUY	$2.48 - $9.65 $310,741 - $1.21 Million	125,299 New	125,299 $1.2 Million
Q4 2023 Feb 12, 2024	BUY	$2.48 - $9.65 $20,336 - $79,130	8,200 Added 7.0%	125,299 $1.2 Million
Q3 2022 Nov 08, 2022	BUY	$2.0 - $3.56 $78,066 - $138,957	39,033 Added 50.0%	117,099 $352,000
Q3 2021 Nov 15, 2021	BUY	$7.83 - $9.41 $611,256 - $734,601	78,066 New	78,066 $618,000

103K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.